Focus on the size of the prize While we are all entitlied to our own opinions, in mine as long as you accept that this is a speculative stock, then there is obsolutely no reason for any negativity whatsoever.
If you discount the facts that perhaps the management should have confirmed that the data being submitted with the FDA application exactly met thier requirements, and the somewhat immoral relationship between CVR Medical and CVR Global; ie both having exactly the same management team allowing them to shamelessly move profit away from shareholders and directly into their own pockets, then operationally this team hasn't put a foot wrong. And btw, I'd expect this relationship issue to be resolved in short order.
We have a product that is not only top of class but that is almost in a class of it's own, quicker, cheaper and more accurate than anything else on the market. A product that, through a very intelligent partnership with Canon, one of the most experienced medical device distributers in the world, is about to be launched GLOBALLY - pretty well all of the information given out by the company so far has focussed on the US, but as many Americans tend to forget; the world is much, much bigger. The investor presentation talks about the U.S. being a $12.5b opportunity - multiply that by the rest of the world, and what figure do you get - I've no clue but it must be absolutely HUGE !!!
I'm sure that the FDA application must be sorted by the end of the year; yes probably a 5/6 month delay on what we originally thought but personally, I'd rather the FDA get it absolutely right, and with the 'size of the prize; whats 6 months in the grand scheme of things. Most of my other investments are in mining stocks and the definition of the word 'imminent' usually means in excess of 12 months, so 6 months is completely acceptable. I for one am really looking forward to 2020!!